📰 Berger News
Page 158 - Berger News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Berger. Real-time updates on events, politics, business and more.
August 7, 2022
The states lobbying group for health-care systems and hospitals has called out state political leaders for being willing to let Medicaid expansion "die because you are looking for a deal."
August 6, 2022
In five to 10 years, we believe every home will have at least one robot that will become a core part of your everyday life: Amazon senior Vice President Dave Limp.
August 6, 2022
Nykaa has confirmed its board's approval for the acquisition of Iluminar Media’s Little Black Book (LBB), a millennial-focused lifestyle discovery platform. This is in line with Nykaa's fundamental, content-first strategy for connecting with its devoted customer base.
August 5, 2022
Twitter says Elon Musk is making up excuses to breach deal
August 4, 2022
The Retirement Income Covenant should not be viewed as another compliance exercise by funds, according to APRA member Margaret Cole, and industry change will be a “marathon not a sprint”
August 4, 2022
Chief Customer Officer at Simpli.fi shares strategies, best practices
August 4, 2022
The deal is unlikely to hurt competition due to the thriving market for security products
August 4, 2022
Board members of Thailand’s telecoms regulator ruled that True and DTAC did not submit enough evidence to showcase how their merger will not stifle competition in the Thai market, a significant blow to the dragged-out merger.
August 4, 2022
On July 28, 2022, the Attorney General of the State of New York (NYOAG) flexed its antitrust muscle and brought suit against CVS Health in Manhattan state court. The NYOAG accuses CVS of violating the Donnelly Act, New Yorks state antitrust law, by illegally tying access to Contract Pharmacy services at CVS retail and specialty pharmacies to use of CVS third-party administrator (TPA) services…
August 4, 2022
Thousand Oaks-based biotech giant Amgen says it is acquiring ChemoCentryx, a publicly traded biopharmaceuticals company which is focused on orally administer